Washington, D.C. 20549







Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

November 29, 2018




(Exact name of registrant as specified in its charter)



Royal Philips

(Translation of registrant’s name into English)

The Netherlands

(Jurisdiction of incorporation or organization)

Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands

(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐            No  ☒

Name and address of person authorized to receive notices

and communications from the Securities and Exchange Commission:

M.J. van Ginneken

Koninklijke Philips N.V.

Amstelplein 2

1096 BC Amsterdam – The Netherlands




This report comprises a copy of the following press release:

“Philips completes cancellation of 24.2 million shares”, dated November 29, 2018.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on the 29th day of November, 2018.


/s/ M.J. van Ginneken

(Chief Legal Officer)


Press Information

November 29, 2018

Philips completes cancellation of 24.2 million shares

Amsterdam, The NetherlandsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 24,246,711 of its shares, as part of Philips’ EUR 1.5 billion share repurchase program, which started in the third quarter of 2017. The cancelled shares were acquired during the period up to and including November 23, 2018.

Under this share repurchase program, which is being executed over a two-year period, Philips has also entered into a number of forward transactions with a number of financial institutions, to be settled at future dates over the course of the program. The program is expected to result in the acquisition and cancellation of an additional 22.7 million shares. Further details can be found here.

Philips’ current issued share capital amounts to 926,195,539 shares.

For further information, please contact:

Martijn van der Starre

Philips Group Press Office

Tel.: +31 6 28474617

E-mail: martijn.van.der.starre@philips.com

Ksenija Gonciarenko

Philips Investor Relations

Tel.: +31 20 5977055

E-mail: ksenija.gonciarenko@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.